vs
ACRES Commercial Realty Corp.（ACR）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
ACRES Commercial Realty Corp.的季度营收约是STANDARD BIOTOOLS INC.的1.0倍（$20.0M vs $19.6M），ACRES Commercial Realty Corp.净利率更高（31.6% vs -177.4%，领先209.0%），ACRES Commercial Realty Corp.同比增速更快（-6.5% vs -11.5%），过去两年ACRES Commercial Realty Corp.的营收复合增速更高（3.3% vs -12.2%）
皮拉马尔地产是一家印度房地产企业，2012年成立，总部位于印度孟买，隶属于皮拉马尔集团。公司专注于住宅及商业地产开发，目前在手开发项目总规模约达1500万平方英尺，知名项目包括Piramal Aranya、Piramal Mahalaxmi等。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ACR vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.0M | $19.6M |
| 净利润 | $6.3M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 30.8% | -168.5% |
| 净利率 | 31.6% | -177.4% |
| 营收同比 | -6.5% | -11.5% |
| 净利润同比 | -32.0% | -28.8% |
| 每股收益（稀释后） | $-0.41 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $20.0M | — | ||
| Q3 25 | $21.0M | $19.6M | ||
| Q2 25 | $21.9M | $21.8M | ||
| Q1 25 | $17.0M | $40.8M | ||
| Q4 24 | $21.4M | — | ||
| Q3 24 | $22.4M | $22.1M | ||
| Q2 24 | $20.9M | $22.5M | ||
| Q1 24 | $18.8M | $45.5M |
| Q4 25 | $6.3M | — | ||
| Q3 25 | $18.0M | $-34.7M | ||
| Q2 25 | $4.3M | $-33.5M | ||
| Q1 25 | $-730.0K | $-26.0M | ||
| Q4 24 | $9.3M | — | ||
| Q3 24 | $8.1M | $-26.9M | ||
| Q2 24 | $6.4M | $-45.7M | ||
| Q1 24 | $4.9M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | 30.8% | — | ||
| Q3 25 | 85.8% | -168.5% | ||
| Q2 25 | 19.8% | -118.1% | ||
| Q1 25 | -3.8% | -80.8% | ||
| Q4 24 | 43.4% | — | ||
| Q3 24 | 36.4% | -120.9% | ||
| Q2 24 | 30.8% | -134.5% | ||
| Q1 24 | 26.2% | -132.2% |
| Q4 25 | 31.6% | — | ||
| Q3 25 | 85.8% | -177.4% | ||
| Q2 25 | 19.8% | -153.7% | ||
| Q1 25 | -4.3% | -63.8% | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 36.0% | -122.0% | ||
| Q2 24 | 30.6% | -203.3% | ||
| Q1 24 | 26.2% | -70.6% |
| Q4 25 | $-0.41 | — | ||
| Q3 25 | $1.34 | $-0.09 | ||
| Q2 25 | $-0.10 | $-0.09 | ||
| Q1 25 | $-0.80 | $-0.07 | ||
| Q4 24 | $0.51 | — | ||
| Q3 24 | $0.36 | $-0.07 | ||
| Q2 24 | $0.21 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $83.8M | $129.4M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $420.8M | $399.7M |
| 总资产 | $2.2B | $539.6M |
| 负债/权益比越低杠杆越低 | 3.68× | — |
8季度趋势，按日历期对齐
| Q4 25 | $83.8M | — | ||
| Q3 25 | $40.9M | $129.4M | ||
| Q2 25 | $42.7M | $158.6M | ||
| Q1 25 | $66.0M | $150.9M | ||
| Q4 24 | $56.7M | — | ||
| Q3 24 | $70.1M | $210.6M | ||
| Q2 24 | $89.6M | $269.8M | ||
| Q1 24 | $84.6M | $287.1M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | $55.2M | ||
| Q2 24 | $1.6B | $55.1M | ||
| Q1 24 | $1.6B | $55.0M |
| Q4 25 | $420.8M | — | ||
| Q3 25 | $432.9M | $399.7M | ||
| Q2 25 | $425.3M | $424.5M | ||
| Q1 25 | $430.1M | $454.6M | ||
| Q4 24 | $439.1M | — | ||
| Q3 24 | $436.3M | $489.3M | ||
| Q2 24 | $434.0M | $510.3M | ||
| Q1 24 | $432.8M | $577.3M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $1.7B | $539.6M | ||
| Q2 25 | $1.8B | $557.0M | ||
| Q1 25 | $1.8B | $579.6M | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $2.0B | $681.5M | ||
| Q2 24 | $2.1B | $708.7M | ||
| Q1 24 | $2.1B | $777.7M |
| Q4 25 | 3.68× | — | ||
| Q3 25 | 2.76× | — | ||
| Q2 25 | 3.10× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 3.12× | — | ||
| Q3 24 | 3.43× | 0.11× | ||
| Q2 24 | 3.67× | 0.11× | ||
| Q1 24 | 3.79× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 0.65× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $4.1M | — | ||
| Q3 25 | $-9.4M | $-22.2M | ||
| Q2 25 | $11.8M | $-20.7M | ||
| Q1 25 | $-4.6M | $-30.3M | ||
| Q4 24 | $19.4M | — | ||
| Q3 24 | $8.4M | $-27.9M | ||
| Q2 24 | $6.9M | $-39.0M | ||
| Q1 24 | $3.3M | $-62.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | 0.65× | — | ||
| Q3 25 | -0.52× | — | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACR
| Other | $10.8M | 54% |
| Pacmulti JVLLC | $5.2M | 26% |
| Mccallum Jv Llc | $2.5M | 12% |
| Office Complex | $1.5M | 7% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
